{'fraction_non_alphanumeric': 0.030139935414424113, 'fraction_numerical': 0.02045209903121636, 'mean_word_length': 5.36986301369863, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Eotaxin influences the development of embryonic hematopoietic progenitors in the mouse

Eotaxin is a potent chemoattractant for eosinophils during inflammation and allergic reactions in the adult, but its role during development has not been studied. We report that eotaxin and its receptor, CCR‐3, are expressed by embryonic tissues responsible for blood development, including the yolk sac, fetal liver, and fetal blood. We also found that eotaxin acts synergistically with stem cell factor (SCF) to accelerate the differentiation of embryonic mast cell progenitors and to promote the growth of Mac‐1+/Gr‐1‐ cells from progenitors isolated at 10‐12 days of gestation. This response is diminished by Pertussistoxin, the Giα inhibitor. These studies suggest that eotaxin is involved in the growth of myeloid cell progenitors and the differentiation of mast cells during embryogenic development. J. Leukoc. Biol.62: 661–666; 1997.